ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG) Form 6-K — May 28, 2026
Ascentage Pharma Group International disclosed that its trustee purchased 100,000 shares on the open market on May 27, 2026, to satisfy vested awards under its 2022 RSU Scheme. The total consideration paid was HK$3,977,000, resulting in an average price of approximately HK$39.77 per share. This purchase represents approximately 0.0268% of the company’s total issued shares. Following this transaction, the trustee holds a total of 2,265,000 shares for the purpose of the RSU Scheme.
Key figures
- Total Debt
- 0
- Debt Amount
- 0
- Total Assets
- 0
- Cash Position
- 0
- Interest Rate
- 0
- Gross Proceeds
- 0
- Offering Price
- 0
- Shares Offered
- 0
- Shares Outstanding
- 0
- Purchase price hkd
- 3977000
- Percentage of outstanding
- 0.0268%
- Total trustee shares held
- 2265000
- Average price per share hkd
- 39.77
- Shares purchased by trustee
- 100000
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.